Overall rank by patents
#6,139
of 50,000 tracked assignees
USPTO PatentsView assignee record - 55 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
According to USPTO PatentsView, Entellus ranks #6,139 of 50,000 tracked US assignees by granted-patent volume, with 55 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R6139 · US Corporation #6,139 · 55 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: East Carolina University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
ASSA Abloy Accessori… · near
39 score
Entellus Medical · this assignee
39 score
Vyaire Medical Capital · near
39 score
Xiamen Galenpoo Kitc… · near
39 score
Ubiome · near
39 score
3D Lighting Innovati… · lowest
7 score
What this shows Entellus Medical, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-RICH, TYPE-USCORP, VEL-FLAT, BOOK-FULL. Volume places it #6,139 of 50,000; Innovation Score 39.4/100 sits in the top 38% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is East Carolina University (±0 grants).
Entellus Medical, Inc. has been granted 55 US utility patents between 2015 and 2024, placing Entellus Medical, Inc. at #6,139 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Entellus Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Entellus sits between ENZO LIFE Sciences, Inc. (55 patents, rank #6,137) and FMC Kongsberg Subsea AS (55 patents, rank #6,145) - the closest US assignees by grant volume. The composite Innovation Score of 39.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 28 grants, compared with 27 in the 2015–2019 window, a +4% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Entellus Medical, Inc.'s 18.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 7 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ENZO LIFE SCIENCES, INC.
55 patents
EUGENE TECHNOLOGY CO., LTD.
55 patents
East Carolina University
55 patents
Ellenberger & Poensgen GmbH
55 patents
Erasmus University Medical Center Rotterdam
55 patents
Exo Imaging, Inc.
55 patents
FLORICULTURA B.V.
55 patents
FMC Kongsberg Subsea AS
55 patents
Entellus Medical, Inc.
55 patents
What this shows Entellus holds 55 patents at rank #6,141, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,141 in granted patent volume.
Other assignees with the most granted patents in Entellus's primary technology class.
Two PlainPatent-derived peer sets for Entellus, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (39 here).
Nearest assignees by average claims per patent (18.1 here).
Entellus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 7.3% |
| 2016 | 10 | 18.2% |
| 2017 | 4 | 7.3% |
| 2018 | 3 | 5.5% |
| 2019 | 6 | 10.9% |
| 2020 | 4 | 7.3% |
| 2021 | 9 | 16.4% |
| 2022 | 1 | 1.8% |
| 2023 | 8 | 14.5% |
| 2024 | 6 | 10.9% |
Top 7 of 7 technology areas
Overall rank by patents
#6,139
of 50,000 tracked assignees
39.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.